Sands Lab Q1 2026: Net loss widens, operating loss improves; strong cash position


  • Consolidated Q1 2026 revenue: 1.83 billion KRW (up from 0.71 billion in Q1 2025, but significantly lower than the average quarterly revenue of 2.9 billion in 2025)
  • Consolidated operating loss: 1.01 billion KRW (improved from 1.09 billion loss in Q1 2025)
  • Consolidated net loss: 0.64 billion KRW (improved from 1.54 billion loss in Q1 2025, but widened from 0.47 billion loss in full year 2025)
  • EPS: -41 won (consolidated)
  • Cash and cash equivalents: 5.9 billion KRW; including financial assets: 39.5 billion KRW (down from 43.7 billion at end of 2025)
  • Net debt: negative (no net debt)
  • No dividends or share buyback/cancellation
  • Credit rating: BB+ (NICE)
  • Subsidiary: AI Deep (80.91% stake) included in consolidation
  • R&D expenses: 0.54 billion KRW (consolidated)

KOSDAQ Filing Information


  • Filing: Quarterly Report (2026.03)
  • Company: SANDS LAB (411080)
  • Submission: SANDS LAB Inc.
  • Receipt: 05-14-2026